VIRPAX PHARMACEUTICALS INC (VRPX) Stock Price, Quote, News and Overview
NASDAQ:VRPX - Nasdaq - US9282512063 - Common Stock - Currency: USD
VRPX Quote, Performance and Key Statistics
VIRPAX PHARMACEUTICALS INC
NASDAQ:VRPX (2/18/2025, 4:27:07 PM)
After market: 0.2871 -0.02 (-7.39%)0.31
-0.02 (-5%)
The current stock price of VRPX is 0.31 USD. In the past month the price increased by 1.97%. In the past year, price decreased by -90.14%.
VRPX Latest News, Press Relases and Analysis
Unusual volume stocks in Tuesday's session
Discover the stocks with unexpected trading volume in today's session on the US markets.
Wondering what's happening in today's pre-market session?
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
What's going on in today's after hours session
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Check out the stocks that are attracting the most attention and driving market activity.
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate
Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.
VRPX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 65.94 | 813.76B | ||
| JNJ | JOHNSON & JOHNSON | 15.51 | 373.16B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 25.65 | 365.47B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.72 | 231.97B | ||
| MRK | MERCK & CO. INC. | 10.9 | 210.69B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.43 | 210.56B | ||
| PFE | PFIZER INC | 8.22 | 144.85B | ||
| SNY | SANOFI-ADR | 13.45 | 135.26B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 47.75 | 110.39B | ||
| GSK | GSK PLC-SPON ADR | 7.81 | 74.71B | ||
| ZTS | ZOETIS INC | 26.43 | 70.60B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 32.33 | 44.07B |
Related stock screener links
About VRPX
Company Profile
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. The company is headquartered in Berwyn, Pennsylvania and currently employs 7 full-time employees. The company went IPO on 2021-02-17. The firm is focused on developing novel and proprietary drug delivery systems across various pain indication. Its drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (CNS) disorders to enhance patients’ quality of life. Its portfolio consists of multiple preclinical stage product candidates: Epoladerm, Probudur, Envelta, AnQlar and NobrXiol. Probudur is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta is an intranasal molecular envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer. The NobrXiol is being developed for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of rare pediatric epilepsy.
Company Info
VIRPAX PHARMACEUTICALS INC
1055 Westlakes Drive, Suite 300
Berwyn PENNSYLVANIA 19380 US
CEO: Anthony Mack
Employees: 7
Company Website: https://virpaxpharma.com/
Phone: 16107274597
VRPX FAQ
What is the stock price of VRPX?
The current stock price of VRPX is 0.31 USD.
What is the symbol for VIRPAX PHARMACEUTICALS INC stock?
The exchange symbol of VIRPAX PHARMACEUTICALS INC is VRPX and it is listed on the Nasdaq exchange.
On which exchange is VRPX stock listed?
VRPX stock is listed on the Nasdaq exchange.
Is VRPX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for VRPX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of VRPX.
Does VRPX stock pay dividends?
VRPX does not pay a dividend.
What is the Price/Earnings (PE) ratio of VRPX?
VRPX does not have a PE ratio as the earnings reported over the last twelve months were negative (-8.83).
What is the Short Interest ratio of VRPX stock?
The outstanding short interest for VRPX is 3.5% of its float.
VRPX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to VRPX. When comparing the yearly performance of all stocks, VRPX is a bad performer in the overall market: 98.53% of all stocks are doing better.
VRPX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to VRPX. Both the profitability and financial health of VRPX have multiple concerns.
VRPX Financial Highlights
Over the last trailing twelve months VRPX reported a non-GAAP Earnings per Share(EPS) of -8.83. The EPS increased by 24.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4352.58% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
VRPX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to VRPX. The Buy consensus is the average rating of analysts ratings from 6 analysts.